ProUroCare Research Development from 2010 to 2026
| PUMD Stock | USD 0.0002 0.00 0.00% |
Research Development | First Reported 2010-12-31 | Previous Quarter 64.7 K | Current Value 61.4 K | Quarterly Volatility 525.4 K |
Check ProUroCare Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ProUroCare Medical's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 1.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. ProUroCare financial statements analysis is a perfect complement when working with ProUroCare Medical Valuation or Volatility modules.
ProUroCare | Research Development | Build AI portfolio with ProUroCare Stock |
Analyzing ProUroCare Medical's Research Development over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Research Development has evolved provides context for assessing ProUroCare Medical's current valuation and future prospects.
Latest ProUroCare Medical's Research Development Growth Pattern
Below is the plot of the Research Development of ProUroCare Medical over the last few years. It is ProUroCare Medical's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ProUroCare Medical's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
ProUroCare Research Development Regression Statistics
| Arithmetic Mean | 201,419 | |
| Geometric Mean | 89,460 | |
| Coefficient Of Variation | 260.85 | |
| Mean Deviation | 239,785 | |
| Median | 71,854 | |
| Standard Deviation | 525,393 | |
| Sample Variance | 276B | |
| Range | 2.2M | |
| R-Value | (0.42) | |
| Mean Square Error | 242.4B | |
| R-Squared | 0.18 | |
| Significance | 0.09 | |
| Slope | (43,732) | |
| Total Sum of Squares | 4.4T |
ProUroCare Research Development History
About ProUroCare Medical Financial Statements
ProUroCare Medical stakeholders use historical fundamental indicators, such as ProUroCare Medical's Research Development, to determine how well the company is positioned to perform in the future. Although ProUroCare Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in ProUroCare Medical's assets and liabilities are reflected in the revenues and expenses on ProUroCare Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ProUroCare Medical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 64.7 K | 61.4 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ProUroCare Medical is a strong investment it is important to analyze ProUroCare Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ProUroCare Medical's future performance. For an informed investment choice regarding ProUroCare Stock, refer to the following important reports:Check out the analysis of ProUroCare Medical Correlation against competitors. For information on how to trade ProUroCare Stock refer to our How to Trade ProUroCare Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Will Health Care Equipment & Supplies sector continue expanding? Could ProUroCare diversify its offerings? Factors like these will boost the valuation of ProUroCare Medical. Anticipated expansion of ProUroCare directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ProUroCare Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
ProUroCare Medical's market price often diverges from its book value, the accounting figure shown on ProUroCare's balance sheet. Smart investors calculate ProUroCare Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since ProUroCare Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between ProUroCare Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ProUroCare Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, ProUroCare Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.